BOCH
ELDN icon

Blue Owl Capital Holdings’s Eledon Pharmaceuticals ELDN Stock Holding History

Blue Owl Capital Holdings’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.37M Sell
1,419,912
-510,000
-26% -$1.2M 1.18% 22
2025
Q4 		$2.91M Buy
1,929,912
+950,000
+97% +$2.26M 0.9% 31
2025
Q3 		$2.54M Sell
979,912
-350,000
-26% -$1.02M 0.79% 31
2025
Q2 		$3.6M Sell
1,329,912
-490,000
-27% -$1.47M 1.16% 23
2025
Q1 		$6.17M Sell
1,819,912
-140,000
-7% -$576K 1.99% 13
2024
Q4 		$8.07M Buy
+1,959,912
New +$7.73M 1.86% 14

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blue Owl Capital Holdings's ELDN Position: Q1 2026 in Review

Blue Owl Capital Holdings reduced its Eledon Pharmaceuticals (ELDN) stake by 26% in Q1 2026, selling an estimated $1.2M and leaving 1,419,912 shares worth $4.37M. The position accounts for 1.18% of the portfolio, ranked #22.

Blue Owl Capital Holdings first reported a position in ELDN in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.07M in Q4 2024. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Blue Owl Capital Holdings held 1,419,912 shares of Eledon Pharmaceuticals worth $4.37M as of Q1 2026.
  • Blue Owl Capital Holdings sold 510,000 Eledon Pharmaceuticals shares in Q1 2026, an estimated $1.2M.
  • Eledon Pharmaceuticals made up 1.18% of Blue Owl Capital Holdings's portfolio in Q1 2026, its #22 holding.
  • Blue Owl Capital Holdings first reported a position in Eledon Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Blue Owl Capital Holdings's Eledon Pharmaceuticals position peaked at $8.07M in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2026, filed 14 May 2026.